On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
On Jan. 8, 2021, the COVID-19 vaccine developed by Moderna has today been given regulatory approval for supply…
On Jan. 8, 2021, Pfizer and BioNTech announced results from an in vitro study conducted by Pfizer and…
On Jan. 7, 2021, Twist Bioscience announced it would supply the U.S. Centers for Disease Control and Prevention…
On Jan. 7, 2021, Oragenics announced entering into a material transfer agreement with Adjuvance Technologies for use of…
On Jan. 7, 2021, LabCorp announced that it had been awarded a contract from the Centers for Disease…
On Jan. 7, 2021, Novavax announced that it had executed an Advance Purchase Agreement with the Commonwealth of…
On Jan. 7, 2021, BioNTech announced publication of preclinical data on its novel mRNA vaccine approach against autoimmune…
On Jan. 7, 2021, PerkinElmer and Oxford Immunotec announce an agreement under which PerkinElmer acquired Oxford Immunotec for…
On Jan. 6, 2021, the U.S. Department of Health and Human Services (HHS) announced the Centers for Disease…
On Jan. 6, 2021, the La Jolla Institute for Immunology announced data that suggest nearly all COVID-19 survivors…
On Jan. 6, 2021, Moderna announced that the European Commission had granted a conditional marketing authorization for COVID-19…
On Jan. 5, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announed that a phase 2/3…
On Jan. 5, 2021, Illumina and Helix announced a collaboration to augment national surveillance infrastructure in the U.S….
On Jan. 5, 2021, AIM ImmunoTech announced that the active AMP-511 Expanded Access Program (EAP) had dosed its…
On Jan. 4, 2021, the FDA announced that the two different mRNA vaccines were shown remarkable effectiveness of…
Greek philosopher Theophrastus (371-287 BCE), the “Father of Botany” wrote of Greeks rotating their staple crops with broad…
On Jan. 4, 2021, Inovio Pharmaceuticals and Advaccine Biopharmaceuticals announced that they had entered into a collaboration and…
On Jan. 4, 2021, Moderna announced a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global…
On Jan. 4, 2021, Moderna announced that Israel’s Ministry of Health (MOH) had given authorization to import the…
On Jan. 4, 2021, Audrey Winkelsas, a 2015 NIH Oxford-Cambridge Scholars Program doctoral student with spinal muscle atrophy…
On Jan. 4, 2021, a research partnership between scientists at Scripps Research and UC San Diego found the…
On Dec. 31, 2020, the World Health Organization (WHO) listed the Comirnaty COVID-19 mRNA vaccine for emergency use,…
On Dec. 31, 2020, Moderna confirmed it had entered into a supply agreement with the government of the…
On Dec. 31, 2020, CytoDyn announced a research manuscript submitted by Nicholas J. Agresti, M.D. had been accepted…
On Dec. 30, 2020, Mateon Therapeutics announced that it had enrolled and treated its first sentinel Part 1…
On Dec. 30, 2020, Bausch Health announced that the Office for Registration of Medicinal Products, Medical Devices and…
On Dec. 30, 2020, the COVID-19 vaccine developed by Oxford University/AstraZeneca was given regulatory approval by the UK…
On Dec. 30, 2020, Medigen Vaccine Biologics announced that it had obtained TFDA Phase 2 IND approval of…
On Dec. 30, 2020, the National Institutes of Health (NIH) announced that the investigational vaccine known as mRNA-1273…